Next Article in Journal
Application of Carboxymethyl Cellulose and Glycerol Monostearate as Binder Agents for Protein Powder Production from Honey Bee Brood Using Foam-Mat Drying Technique
Next Article in Special Issue
Antioxidant Ready-to-Use Grape Pomace Extracts Recovered with Natural Eutectic Mixtures for Formulation of Color-Rich Gummies
Previous Article in Journal
Microbial Decontamination of Cuminum cyminum Seeds Using “Intensification of Vaporization by Decompression to the Vacuum”: Effect on Color Parameters and Essential Oil Profile
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 13
Issue 14
10.3390/foods13142266
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bioactivity-Guided Isolation of Secondary Metabolites with Antioxidant and Antimicrobial Activities from Camellia fascicularis

by
Ruonan Li
1,
Jiandong Tang
1,
Jingjing Li
1,
Boxiao Wu
1,
Junrong Tang
1,
Huan Kan
1,
Ping Zhao
1,
Yingjun Zhang
2,
Weihua Wang
1 and
Yun Liu
1,*
1
Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China
2
State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650224, China
*
Author to whom correspondence should be addressed.
Foods 2024, 13(14), 2266; https://doi.org/10.3390/foods13142266
Submission received: 20 June 2024 / Revised: 12 July 2024 / Accepted: 17 July 2024 / Published: 18 July 2024
(This article belongs to the Special Issue Separation and Identification of Natural Antioxidant Extracts in Foods)
Browse Figure
Versions Notes

Abstract

:
Camellia fascicularis has important ornamental, medicinal, and food values, which also have tremendous potential for exploiting bioactivities. We performed the bioactivity-guided (antioxidant and antimicrobial) screening of eight fractions obtained from the ethyl acetate phase of C. fascicularis. The antioxidant activity was measured by DPPH, ABTS, and FRAP, and the antibacterial activity was measured by the minimum inhibitory concentration (MIC) of Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. The results of bioactivity-guided isolation indicated that the major antioxidant compounds in the ethanolic extracts of C. fascicularis may be present in fractions (Fr.) (A–G, obtained after silica gel column chromatography). Fr. (D–I, obtained after silica gel column chromatography) is a fraction of C. fascicularis with antimicrobial activity. The structures of compounds were determined by spectral analysis and nuclear magnetic resonance (NMR) combined with the available literature on secondary metabolites of C. fascicularis leaves. In this study, 17 compounds were identified, including four phenolics (1, 3–4, and 14), a phenylpropane (2), five terpenoids (5–7, 12, and 15), four flavonoids and flavonoid glycosides (8–10 and 16), and two lignins (13 and 17). Compounds 4–7, 13–15, and 17 were isolated from the genus Camellia for first time. The remaining compounds were also isolated from C. fascicularis for first time. The evaluation of antioxidant and antimicrobial activities revealed that compounds 1, 3, 9, 11, and 17 exhibited higher antioxidant activity than the positive control drug (ascorbic acid), and compounds 4, 8, 10, and 13 showed similar activity to ascorbic acid. The other compounds had weaker or no significant antioxidant activities. The MIC of antibacterial activity for compounds 4, 7, and 11–13 against P. aeruginosa was comparable to that of the positive control drug tetracycline at 125 µg/mL, and other secondary metabolites inhibited E. coli and S. aureus at 250–500 µg/mL. This is also the first report of antioxidant and antimicrobial activities of compounds 5–7, 13–15, and 17. The results of the study enriched the variety of secondary metabolites of C. fascicularis and laid the foundation for further research on the pharmacological efficacy and biological activity of this plant.

1. Introduction

Camellia fascicularis, a genus of Camellia in the family Theaceae, is an endemic plant in Yunnan province, China. C. fascicularis, which is a rare species resource with unique golden petals and is also known as “giant panda in the plant kingdom”, “queen of the tea family”, and “living fossil of plants”, was first discovered in the Hekou County and was only distributed in the Gejiu, Maguan, and Hekou counties [1]. C. fascicularis leaves possess high amino acid and mineral content and are considered as an edible plant resource with high nutritional and health values [2,3]. There is limited literature on the metabolites of Camellia, with polyphenols (catechin), flavonoids (flavonoids are classified into various types depending on their chemical structure, degree of unsaturation, and oxidation of carbon ring, including flavones, flavanones, isoflavones, flavonols, chalcones, flavanols, and anthocyanins; each of these flavonoids is widely distributed in nature), saponins (mainly flavonoids combined with glycosides to form flavonoid glycosides and oleanoid-type pentacyclic triterpenoid saponins), and steroids (mainly in the form of steroids and steroidal saponins), which are the involved primary active components [4,5,6,7,8]. It has been proved by experiments that the flowers and leaves of C. fascicularis, in addition to being used as tea, have many pharmacological effects such as antioxidant [9], anti-tumour [10,11], and anti-inflammatory [12,13]. Due to its limited distribution in Yunnan, the investigation into secondary metabolites of C. fascicularis commenced relatively late; however, it holds immense potential for exploring the biological activities of C. fascicularis.
The isolation and identification of monomeric active compounds from complex plant components are a pivotal objective in the field of natural product chemistry research [14]. Activity evaluation-oriented chemical component isolation is an effective method to discover and identify phytochemical active components in the process of chemical component isolation and purification, activity evaluation is used to locate the parts or fractions where the plant active components are located, and targeted isolation and purification is carried out on the identified active parts or streams to ultimately obtain the chemical active components of the Traditional Chinese Medicine [15]. This greatly improves the separation efficiency of the active ingredients, and many structurally defined plant active ingredients are obtained by this method [16]. The significance of the existing research findings is considered in exploring the bioactivities of C. fascicularis. Therefore, the present study was oriented towards antioxidant and antibacterial activities, using a combination of multiple spectral separation techniques to isolate and purify the antioxidant and antibacterial active components from C. fascicularis, and their structural identification was carried out to preliminarily explore the structure–activity relationships in order to provide a theoretical reference and basis.

2. Materials and Methods

2.1. Instrumentation

The following instruments were utilized in the experiments: Bruker AV 500 MHz Nuclear Magnetic Resonance Instrument (Bruker, Saarbrucken, Germany), XEVO G2-XS Q-Tof High-Resolution Mass Spectrometer (Waters, Milford, MA, USA), NP7000 Semi-preparative Liquid Phase (Jiangsu Hanbang Technology Co., Ltd., Huaian, China), AX224ZH\E Electronic Balance (Ohaus Instruments, Changzhou Co., Ltd., Changzhou, China), N-1300 Rotary Evaporator, CA-111 Cold Trap (Shanghai Ailang Instrument Co., Ltd., Shanghai, China), SHZ-DIII Circulating Water Vacuum Pump (Gongyi Yu Hua Instrument Co., Ltd., Gongyi, China), SpectraMax 190 enzyme labeller (Molecular Devices Co., Ltd., Shanghai, China), ZQZY-CF9.9 oscillating incubator (Shanghai Zhichu Instrument Co., Ltd., Shanghai, China), and ZF-7 triple-use UV analyser (Shanghai Jiapeng Science and Technology Co., Ltd., Shanghai, China).

2.2. Chemicals and Reagents

2,2-Diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,4,6-tris(2-pyridyl)-S-triazine, (TPTZ), and ascorbic acid were obtained from Beijing Solarbio Science & Technology Co., Ltd. (Beijing, China). Methanol (HPLC grade) was purchased from Shanghai Xingke High Purity Solvent Co., Ltd. (Shanghai, China). Dimethyl sulfoxide (DMSO) and all other chemicals of analytical grade were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Macroporous resin D101 and Sephadex LH–20 were purchased from Shanghai Yuanye Biotechnology Co., Ltd. (Shanghai, China), column chromatography silica gel (200–300 mesh and 300–400 mesh) and thin-layer chromatography silica gel plates were purchased from Qingdao Ocean Chemical Co., Ltd. (Qingdao, China), and middle chromatogram isolated (MCI) reversed-phase column was purchased from Beijing Lvbaicao Technology Development Co., Ltd. (Beijing, China). The reagents (industrial grade) used in the column chromatography process were purchased from Yunnan Liyan Technology Co Ltd. (Kunming, China).

2.3. Plant Material

The voucher specimen (52860) of C. fascicularis was identified by taxonomist Min Tianlu and preserved in the Herbarium of Kunming Institute of Botany, Chinese Academy of Sciences. The leaves of C. fascicularis used in this experiment were obtained from Dawei Mountain Nature Reserve, Hekou County, Yunnan Province, China, in December 2019, and were identified as C. fascicularis by taxonomist Prof. Xiang Jianying of Southwest Forestry University.

2.4. Extraction and Isolation

A total of 10.7 kg of the dried C. fascicularis leaf sample was pulverized to about 40 mesh and then extracted three times with 95% methanol at 50 °C for 3, 2, and 1 h each time, respectively. After combining the extracts and evaporating the solvents under low pressure at 50 °C, the methanolic extract of C. fascicularis (868.3 g) was obtained. Subsequently, 5 L of distilled water was added for thorough mixing, followed by three extractions using an equal volume of industrial ethyl acetate. The ethyl acetate phase extract (177.8 g) was obtained through low-pressure rotary evaporation at 40 °C. The ethyl acetate phase extract was mixed with (267.0 g) of macroporous resin and loaded onto the column and eluted with a gradient of CH3OH:H2O (0:1→1:0), and the same portions were combined by thin-layer chromatography (TLC) detection as 4 fractions (Fr. I–IV). After the preliminary screening of Fr. (I–IV) for TLC and antioxidant activity, Fr. (II–III) was found to have good TLC site formation and better antioxidant activity than the other fractions (DPPH IC50: 69.44 ± 2.92/µg/mL; ABTS IC50: 151.23 ± 12.75/µg/mL). The combined portion of (45.0 g) (Fr. II–III) of the extract was subjected to silica gel column chromatography, with the gradient elution of CHCl3:CH3OH (1:0→0:1), and the same portion of the combined fractions was obtained by TLC detection as 8 fractions [17] (Table 1).
Fr. A (VCHCl3:CH3OH = 50:1) elution fraction (6.0 g) was separated by MCI reversed-phase column chromatography and gradient elution with MeOH:H2O (2:3, 1:1, 3:2, 7:3, 4:1, 9:1, 10:0, v/v) to obtain 9 flow fractions (Aa–Ai). Fr. Ah was further purified, and impurities were removed using Sephadex LH–20 (CH2Cl2:MeOH = 95:5), followed by separation by elution with small orthophase silica gel (CH2Cl2:MeOH), and finally purified using preparative high-performance liquid chromatography (PHPLC) to give monomeric compounds 1 (5.1 mg, Vmethanol:water = 53:47, tR = 15 min), 2 (4.5 mg, Vmethanol:water = 78:22, tR = 7 min), and 3 (7.1 mg, Vmethanol:water = 59:41, tR = 10 min). Fr. Aa was further purified, and impurities were removed using Sephadex LH–20 (CH2Cl2:MeOH = 95:5), followed by separation by elution with small orthophase silica gel (CH2Cl2:MeOH), and finally purified using PHPLC to give monomeric compound 5 (3.5 mg, Vmethanol:water = 23:77, tR = 33 min). Fr. Ac was further purified, and impurities were removed using Sephadex LH–20 (CH2Cl2:MeOH = 95:5), followed by separation by elution with small orthophase silica gel (CH2Cl2:MeOH), and finally purified using PHPLC to give monomeric compounds 4 (4.2 mg, Vmethanol:water = 37–87, tR = 12 min), 6 (3.9 mg, Vmethanol:water = 20–100, tR = 26 min), and 7 (2.4 mg, Vmethanol:water = 35–95, tR = 20 min).
Fr. F (VCHCl3:CH3OH = 5:1) elution fraction (5.0 g) was separated by MCI reversed-phase column chromatography and gradient elution with MeOH:H2O (2:3, 1:1, 3:2, 7:3, 4:1, 9:1, 10:0, v/v) to obtain 9 flow fractions (Fa–Fi). Fr. Fi was further purified, and impurities were removed using Sephadex LH–20 (MeOH:H2O = 95:5) to give compound 10 (4.2 mg), and finally purified using PHPLC to give monomeric compounds 8 (3.5 mg, Vmethanol:water = 76:24, tR = 13 min) and 9 (4.2 mg, Vmethanol:water = 43:57, tR = 8 min). Fr. Fc was further purified, and impurities were removed using Sephadex LH–20 (MeOH:H2O = 95:5), and finally purified using PHPLC to give monomeric compound 11 (3.4 mg, Vmethanol:water = 63:37, tR = 14 min). Fr. Fd was further purified, and impurities were removed using Sephadex LH–20 (MeOH:H2O = 95:5), and finally purified using PHPLC to give monomeric compounds 12 (4.5 mg) and 13 (10.3 mg, Vmethanol:water = 37:63, tR = 14 min). Fr. Fa was further purified, and impurities were removed using Sephadex LH–20 (MeOH:H2O = 95:5), and finally purified using PHPLC to give monomeric compound 14 (9.3 mg, Vmethanol:water = 27:73, tR = 19 min).
Fr. G (VCHCl3:CH3OH = 2:1) elution fraction (9.0 g) was separated by MCI reversed-phase column chromatography and gradient elution with MeOH:H2O (2:3, 1:1, 3:2, 7:3, 4:1, 9:1, 10:0, v/v) to obtain 9 flow fractions (Ga–Gi). Fr. Gh was further purified, and impurities were removed using Sephadex LH–20 (CH2Cl2:MeOH = 1:1), followed by separation by elution with small orthophase silica gel (CH2Cl2:MeOH), and finally purified using PHPLC to give monomeric compound 15 (3.4 mg, Vmethanol:water = 93:7, tR = 8 min). Fr. Gd was further purified and decontaminated using Sephadex LH–20 (CH2Cl2: MeOH = 1:1) to give compound 16 (3.6 mg).
Fr. D (VCHCl3:CH3OH = 15:1) elution fraction (4.0 g) was separated by MCI reversed-phase column chromatography and gradient elution with MeOH:H2O (2:3, 1:1, 3:2, 7:3, 4:1, 9:1, 10:0, v/v) to obtain 8 flow fractions (Da–Dh). Fr. Dc was further purified, and impurities were removed using Sephadex LH–20 (CH2Cl2:MeOH = 95:5), followed by separation by elution with small orthophase silica gel (CH2Cl2:MeOH), and finally purified using PHPLC to give monomeric compound 17 (3.0 mg, Vmethanol:water = 43:57, tR = 12 min).
After purification to obtain the monomeric compounds, the organic solvent was evaporated and weighed, and a suitable deuterium substitute reagent was selected for dissolution and sent for testing, and TMS was used as an internal standard.

2.5. Chemical Structure Analysis

The results of bioactivity-guided isolation indicated that the major antioxidant compounds in the ethanolic extracts of C. fascicularis may be present in Fr. (A–G). Fr. (D–I) is a fraction of C. fascicularis with antimicrobial activity. The structures of compounds were determined by spectral analysis and nuclear magnetic resonance (NMR) combined with the available literature on secondary metabolites of C. fascicularis leaves, which afforded 17 compounds, including fours phenolics (1, 3–4, 14), a phenylpropane (2), five terpenoids (5–7, 12, 15), four flavonoids and flavonoid glycosides (8–10, 16), and two lignins (13, 17). Compounds 4–7, 13–15, and 17 were isolated from the genus Camellia for the first time. The remaining compounds were also isolated from this plant for the first time.
The structures in Figure 1 are of the following known compounds: ethyl gallate (1) [18], 4-methoxycinnamic acid (2) [19], ferulic acid (3) [20], evofolin B (4) [18], vomifoliol (5) [21], (6R,7E,9S)-9-hydroxy-4,7-megastigmadien-3-one (6) [22], (2-cis,4-trans)-abscisic acid (7) [23], hesperetin (8) [24], quercetin (9) [25], apigenin (10) [26], ellagic acid (11) [27], oleanolic acid (12) [28], dihydrodehydrodiconiferyl alcohol-4-O-β-D-glucopyranoside (13) [29], 3-Methoxy-4-hydroxyphenol 1-O-β-D-(6′-O-galloyl)-glucopyranoside (14) [30], 3-O-α-L-rhamnopyranosyl-(1→4)-β-D-galactopyranosyl-(1→3)-[β-D-glucopyranosyl-(1→2)]-β-D-glucuronopyranosyl 22-O-angeloyl-A1-barrigenol (15) [31], naringin (16) [32], and icario A2 (17) [33].
Ethyl gallate (1): white powder, HRESIMS m/z 199.0675 [M + H]+ (calcd. for C9H10O5); 1H NMR (500 MHz, methanol-d4) δH 7.06 (2H, s, H-2, 6), 4.26 (2H, d, J = 7.1 Hz, H-8), 1.32 (3H, t, J = 7.2 Hz, H-9). 13C NMR (126 MHz, methanol-d4) δC 168.7 (C-7), 146.6 (C-3, 5), 139.8 (C-4), 121.9 (C-7), 110.2 (C-2, 6), 61.8 (C-8), 14.7 (C-9).
4-Methoxycinnamic acid (2): white powder, HRESIMS m/z 179.0721 [M + H]+ (calcd. for C10H10O3); 1H NMR (500 MHz, methanol-d4) δH 7.62 (1H, d, J = 15.9 Hz, H-7), 7.53 (1H, d, J = 8.8 Hz, H-2, 6), 6.94 (1H, d, J = 8.8 Hz, H-3, 5), 6.32 (1H, d, J = 15.9 Hz, H-8), 3.82 (2H, s, OMe). 13C NMR (126 MHz, methanol-d4) δC 170.8 (C-9), 163.1 (C-4), 146.2 (C-7), 130.9 (C-2, 6), 128.4 (C-1), 116.6 (C-8), 115.4 (C-3, 5), 55.9 (4-OMe).
Ferulic acid (3): colourless needle crystal, HRESIMS m/z 195.0672 [M + H]+ (calcd. for C10H10O4); 1H NMR (500 MHz, methanol-d4) δH 7.58 (1H, d, J = 16.0 Hz, H-7), 7.15 (1H, d, J = 2.0 Hz, H-2), 7.04 (1H, dd, J = 8.2, 2.0 Hz, H-6), 6.80 (1H, d, J = 8.2 Hz, H-5), 6.29 (1H, d, J = 15.9 Hz, H-8), 3.87 (3H, s, 3-OMe). 13C NMR (126 MHz, methanol-d4) δC 171.0 (C-9), 150.5 (C-3), 149.3 (C-4), 146.9 (C-7), 127.8 (C-1), 123.9 (C-6), 116.4 (C-5), 115.9 (C-8), 111.6 (C-2), 56.4 (3-OMe).
Evofolin B (4): brownish yellow powder, HRESIMS m/z 319.1219 [M + H]+ (calcd. for C17H18O6); 1H NMR (500 MHz, methanol-d4) δH 7.62 (1H, dd, J = 8.4, 2.0 Hz, H-6), 7.57 (1H, d, J = 2.0 Hz, H-2), 6.90 (1H, d, J = 1.9 Hz, H-2′), 6.80 (1H, d, J = 8.3 Hz, H-5), 6.76 (1H, dd, J = 8.2, 2.0 Hz, H-6′), 6.73 (1H, d, J = 8.1 Hz, H-5′), 4.76 (1H, dd, J = 8.8, 5.2 Hz, H-7′), 4.25 (1H, dd, J = 10.7, 8.8 Hz, H-8′), 3.87 (3H, s, 3-OMe), 3.83 (3H, s, 3′-OMe), 3.71 (1H, dd, J = 10.6, 5.2 Hz, H-8′). 13C NMR (126 MHz, methanol-d4) δC 199.6 (C-7), 153.2 (C-3), 149.1 (C-6), 149.3 (C-4), 149.0 (C-4′), 130.5 (C-1), 129.9 (C-1′), 124.4 (C-6), 121.1 (C-6′), 116.6 (C-5′), 115.7 (C-5), 112.8 (C-2), 112.6 (C-2‘), 65.5 (C-8′), 56.4 (3-OMe), 56.3 (3′-OMe).
Vomifoliol (5): white crystal, HRESIMS m/z 247.1358 [M + Na]+ (calcd. for C13H20O3); 1H NMR (500 MHz, methanol-d4) δH 5.89–5.87 (1H, m, H-4), 5.81–5.75 (2H, m, H-7,8), 4.37–4.27 (1H, m, H-9), 2.49 (1H, d, J = 16.9 Hz, H-2a), 2.16 (1H d, J = 17.1 Hz, H-2b), 1.92 (3H, d, J = 1.3 Hz, H-11), 1.25 (3H, d, J = 6.5 Hz, H-10), 1.05 (3H, s, H-12), 1.02 (3H, s, H-13). 13C NMR (126 MHz, methanol-d4) δC 200.7 (C-3), 166.9 (C-5), 136.4 (C-8), 129.5 (C-7), 126.6 (C-4), 79.5 (C-6), 68.1 (C-9), 50.2 (C-2), 41.9 (C-1), 24.0 (C-13), 23.3 (C-10), 22.9 (C-12), 19.0, (C-11).
(6R,7E,9S)-9-Hydroxy-4,7-megastigmadien-3-one (6): colourless oily, HRESIMS m/z 209.1586 [M + H]+ (calcd. for C13H20O2); 1H NMR (500 MHz, methanol-d4) δH 5.88 (1H, s, H-4), 5.70 (1H, dd, J = 15.3, 5.8 Hz, H-8) 5.58 (1H, dd, J = 15.3, 9.2 Hz, H-7), 4.33–4.18 (1H, m, H-9), 2.67 (d, J = 9.2 Hz, 1H), 2.40 (1H, d, J = 16.8 Hz, H-2b), 2.05 (1H, d, J = 16.8 Hz, H-2a), 1.94 (3H, m, H-13), 1.24 (3H, d, J = 9.4 Hz, H-10), 1.03 (3H, s, H-11), 1.00 (3H, s, H-12). 13C NMR (126 MHz, methanol-d4) δC 202.2 (C-3), 166.2 (C-5), 140.4 (C-8), 127.4 (C-7), 126.3 (C-4), 68.9 (C-9), 56.8 (C-6), 37.3 (C-1), 27.5 (C-11), 23.9 (C-13), 23.9 (C-10).
(2-cis,4-trans)-Abscisic acid (7): white amorphous powder, HRESIMS m/z 287.1307 [M + H]+ (calcd. for C15H20O4); 1H NMR (500 MHz, methanol-d4) δH 7.76 (1H, d, J = 16.2 Hz, H-4), 6.22 (1H, d, J = 16.2 Hz, H-5), 5.92 (1H, s, H-8), 5.75 (1H, s, H-2), 2.53 (1H, d, J = 16.9 Hz, H-10a), 2.18 (1H, d, J = 16.8 Hz, H-10b), 2.02 (3H, d, J = 1.2 Hz, H-15), 1.93 (3H, d, J = 1.4 Hz, H-14), 1.06 (3H, s, H-12), 1.02 (3H, s, H-13). 13C NMR (126 MHz, methanol-d4) δC 201.4 (C-9), 166.9 (C-1, 3), 150.4 (C-7), 137.8 (C-5), 129.8 (C-4), 127.8 (C-8), 120.8 (C-2), 80.9 (C-6), 51.0 (C-10), 43.2 (C-11), 25.0 (C-12), 23.9 (C-13), 21.5 (C-15), 20.0 (C-14).
Hesperetin (8): pale yellow crystals, HRESIMS m/z 303.1002 [M + H]+ (calcd. for C16H14O6); 1H NMR (500 MHz, methanol-d4) δH 6.96 (1H, d, J = 2.3 Hz, H-2′), 6.94 (s, 1H), 6.91 (1H, dd, J = 8.3, 2.1 Hz, H-5′), 5.91 (1H, d, J = 2.2 Hz, H-6), 5.89 (1H, d, J = 2.2 Hz, H-8), 5.33 (1H, dd, J = 12.7, 3.1 Hz, H-8), 3.87 (3H, s, OMe), 3.07 (1H, dd, J = 17.1, 12.7 Hz, H-3b), 2.72 (1H, dd, J = 17.1, 3.1 Hz, H-3a). 13C NMR (126 MHz, methanol-d4) δC 197.6 (C-4), 168.4 (C-7), 165.5 (C-5), 164.8 (C-9), 149.4 (C-4′), 147.8 (C-3′), 133.2 (C-1′), 119.0 (C-6′), 114.5 (C-2′), 112.6 (C-5′), 103.4 (C-10), 97.1 (C-6), 96.2 (C-8), 80.3 (C-2), 56.4 (OMe), 44.1 (C-3).
Quercetin (9): yellow powder, HRESIMS m/z 301.0496 [M − H]− (calcd. for C15H10O7); 1H NMR (500 MHz, methanol-d4) δH 7.71 (1H, d, J = 2.2 Hz, H-2′), 7.60 (1H, dd, J = 8.5, 2.2 Hz, H-6′), 6.86 (1H, d, J = 8.5 Hz, H-5′), 6.36 (1H, d, J = 2.1 Hz, H-8), 6.15 (1H, d, J = 2.1 Hz, H-6). 13C NMR (126 MHz, methanol-d4) δC 177.3 (C-4), 165.6 (C-7), 162.5 (C-5), 158.2 (C-9), 148.8 (C-2), 147.9 (C-4′), 146.2 (C-3′), 137.3 (C-3), 124.2 (C-1′), 121.7 (C-6′), 116.2 (C-5′), 115.9 (C-2′), 104.5 (C-10), 99.2 (C-6), 94.4 (C-8).
Apigenin (10): pale yellow powder, HRESIMS m/z 271.1464 [M + H]+ (calcd. for C15H10O5); 1H NMR (500 MHz, DMSO-d6) δH 12.97 (1H, s, 5-OH), 7.93 (2H, d, J = 8.9 Hz, H-2′, 6′), 6.93 (2H, d, J = 8.8 Hz, H-3′, 5′), 6.78 (1H, s, H-3), 6.48 (1H, d, J = 2.1 Hz, H-8), 6.19 (1H, d, J = 2.0 Hz, H-6). 13C NMR (126 MHz, DMSO-d6) δC 181.9 (C-4), 164.3 (C-2), 163.9 (C-7), 161.6 (C-4′), 157.5 (C-5), 128.7 (C-2′, 6′), 121.3 (C-1′), 116.1 (C-3′, 5′), 103.9 (C-10), 99.0 (C-6), 94.1 (C-8).
Ellagic acid (11): pale yellow powder, HRESIMS m/z 303.1231 [M + H]+ (calcd. for C14H6O8); 1H NMR (500 MHz, DMSO-d6) δH 7.46 (2H, S, H-5). 13C NMR (126 MHz, DMSO-d6) δC 159.3 (C-7, 3′), 148.3 (C-4, 4′), 133.8 (C-2, 2′), 136.6 (C-3, 3′), 112.5 (C-6, 6′), 110.4 (C-5, 5′), 107.8 (C-1, 1′).
Oleanolic acid (12): white powder, HRESIMS m/z 455.3527 [M – H]− (calcd. for C30H48O3); 1H NMR (500 MHz, methanol-d4) δH 5.22 (1H, t, J = 3.7 Hz, H-12), 3.13 (1H, dd, J = 11.4, 4.8 Hz, H-3a), 2.83 (1H, dd, J = 13.9, 4.6 Hz, H-18b), 1.14 (1H, s, 27-Me), 0.95 (3H, s, 23-Me), 0.92 (3H, s, 29-Me), 0.89 (3H, s, 24-Me), 0.80 (3H, s, 25-Me), 0.76 (3H, s, 26-Me). 13C NMR (126 MHz, methanol-d4) δC 182.0 (C-28), 145.4 (C-13), 123.8 (C-12), 79.9 (C-3), 56.9 (C-5), 47.8 (C-9), 47.5 (C-19), 47.4 (C-17), 43.0 (C-14), 42.9 (C-18), 40.7 (C-8), 40.0 (C-4), 38.3 (C-1), 35.0 (C-10), 34.2 (C-21), 34.0 (C-30), 33.7 (C-22), 31.8 (C-7), 29.0 (C-20), 28.9 (C-23), 28.0 (C-15), 26.6 (C-2), 24.7 (C-29), 24.2 (C-16), 24.1 (C-11), 19.7 (C-6), 17.9 (C-26), 16.5 (C-25), 16.0 (C-24).
Dihydrodehydrodiconiferyl alcohol-4-O-β-D-glucopyranoside (13): white powder, HRESIMS m/z 545.2504 [M + Na]+ (calcd. for C26H34O11); 1H NMR (500 MHz, methanol-d4) δH 7.16 (1H, d, J = 8.4 Hz, H-5), 7.05 (1H, d, J = 2.0 Hz, H-2), 6.95 (1H, dd, J = 8.3, 2.0 Hz, H-6), 6.75 (1H, s, H-6′), 6.73 (1H, s, 2′), 5.57 (1H, d, J = 5.8 Hz, H-7), 4.91 (1H, s, H, Glc-1), 3.88 (3H, s, 3′-OMe), 3.85 (3H, s, 3-OMe), 3.80 (1H, s, H-9a), 3.57 (1H, t, J = 6.4 Hz, H-8), 2.64 (2H, dd, J = 8.7, 6.7 Hz, H-7′), 1.86–1.80 (2H, m, H-8′). 13C NMR (126 MHz, methanol-d4) δC 151.1 (C-3), 147.8 (C-4), 147.7 (C-4′), 145.4 (C-3′), 138.5 (C-1), 137.3 (C-1′), 129.8 (C-5′), 119.5 (C-6), 118.2 (C-5), 118.1 (C-2′), 114.3 (C-6′), 111.3 (C-2), 102.9 (Glc, C-1), 88.6 (C-7), 78.4 (Glc, C-3), 78.0 (Glc, C-5), 75.1 (Glc, C-2), 71.5 (Glc, C-4), 65.2 (C-9), 62.7 (Glc, C-6), 62.4 (C-9′), 56.9 (3-OMe), 56.9 (3′-OMe), 55.8 (C-8), 35.9 (C-8′), 33.1 (C-7′).
3-Methoxy-4-hydroxyphenol 1-O-β-D-(6′-O-galloyl)-glucopyranoside (14): white powder, HRESIMS m/z 477.1048 [M + Na + H]+ (calcd. for C20H21O12); 1H NMR (500 MHz, methanol-d4) δH 7.10 (2H, s, H-2″, 6″), 6.70 (1H, d, J = 2.7 Hz, H-5), 6.62 (1H, d, J = 8.6 Hz, H-2), 6.57 (1H, dd, J = 8.6, 2.7 Hz, H-6), 4.73 (1H, d, J = 7.4 Hz, H-1′), 4.59 (1H, dd, J = 11.9, 2.1 Hz, H-6a′), 4.43 (1H, dd, J = 11.9, 6.7 Hz, H-6b′), 3.92–3.76 (1H, m, H-5′), 3.71 (3H, s, -OMe), 3.50–3.39 (3H, m, H-2′, 3′, 4′). 13C NMR (126 MHz, methanol-d4) δC 168.3 (C-7″), 152.7 (C-1), 149.2 (C-3), 146.6 (C-3″, 5″), 143.1 (C-4), 139.9 (C-4′), 121.4 (C-1′), 116.1 (C-5), 110.2 (C-2′, 6′), 110.2 (C-6), 103.9 (C-1′), 103.9 (C-2), 77.9 (C-3′), 75.7 (C-5′), 74.9 (C-2′), 71.8 (C-4′), 64.9 (C-6′), 56.3 (-OMe).
3-O-α-L-rhamnopyranosyl-(1→4)-β-D-galactopyranosyl-(1→3)-[β-D-glucopyranosyl-(1→2)]-β-D-glucuronopyranosyl 22-O-angeloyl-A1-barrigenol (15): white powder, HRESIMS m/z 1219.5961 [M + H]+ (calcd. for C59H94O26); 1H NMR (500 MHz, methanol-d4) δH 1.11 (1H, m, H-1a), 1.68 (1H, m, H-2), 1.65 (1H, d, J = 13.2 Hz, H-1b), 3.29 (1H, dd, J = 13.2, 4.2 Hz, H-3), 0.72 (1H, d, J = 12.3 Hz, H-5), 1.50–1.42 (2H, m, H-6), 1.73–1.64 (2H, m, H-7), 1.59–1.52 (1H, m, H-9), 1.97–1.84 (2H, m, H-11), 5.43 (1H, t, J = 3.9 Hz, H-12), 3.79–3.63 (1H, m, H-15), 3.87 (1H, d, J = 4.9 Hz, H-17), 2.49 (1H, dd, J = 13.2, 4.6 Hz, H-18), 2.41 (1H, t, J = 13.3 Hz, H-19), 1.09–0.92 (1H, m, H-19), 1.51 (1H, d, J = 12.3 Hz, H-21), 2.31 (1H, t, J = 12.4 Hz, H-21), 5.45 (1H, dd, J = 12.0, 5.0 Hz, H-18), 1.05 (3H, s, H-23), 0.85 (3H, s, H-24), 0.95 (3H, s, H-29), 1.07 (3H, s, H-26), 1.36 (3H, s, H-27), 3.11 (2H, d, J = 11.3 Hz, H-21), 0.89 (3H, s, H-27), 1.03 (3H, s, H-30), 6.04 (1H, s, H-3′), 1.95 (3H, d, J = 7.1 Hz, H-4′), 1.88 (3H, d, J = 1.9 Hz, H-5′), 4.43 (1H, d, J = 8.6 Hz, GlcA, H-1), 3.93 (1H, d, J = 8.4 Hz, GlcA, H-2), 4.10 (1H, d, J = 8.8 Hz, GlcA, H-3), 3.65 (1H, d, J = 9.6 Hz, GlcA, H-4), 3.79 (1H, d, J = 9.4 Hz, GlcA, H-5), 4.89 (1H, d, J = 6.8 Hz, Glc, H-1), 3.23 (1H, d, J = 8.8 Hz, Glc, H-2), 3.33 (1H, d, J = 8.9 Hz, GlcA, H-3), 3.10 (1H, t, J = 8.8 Hz, Glc, H-4), 3.40–3.33 (1H, m, Glc, H-5), 3.58 (1H, dd, J = 12.4, 4.8Hz, Glc, H-6), 5.11 (1H, d, J = 8.1 Hz, Gal, H-1), 3.79 (1H, d, J = 8.8 Hz, Gal, H-2), 3.67 (1H, dd, J = 9.4, 3.4Hz, Gal, H-3), 3.73 (1H, d, J = 3.8 Hz, Gal, H-4), 3.48 (1H, dd, J = 8.2, 3.7Hz, Gal, H-5), 3.63 (1H, dd, J = 11.4, 3.8Hz, Gal, H-6a), 3.80 (1H, dd, J = 11.7, 7.8Hz, Gal, H-6b), 5.23 (1H, s, Rha, H-1), 3.91 (1H, d, J = 1.8 Hz, Rha, H-2), 3.72 (1H, dd, J = 9.4, 3.1 Hz, Rha, H-3), 3.44 (1H, t, J = 8.3 Hz, Rha, H-4), 4.08 (1H, dd, J = 9.2, 5.7Hz, Rha, H-5), 1.25 (1H, d, J = 6.4 Hz, Rha, H-6), 13C NMR (126 MHz, methanol-d4) δC 170.8 (GlcA C-6), 169.4 (C-1′), 144.3 (C-13), 129.8 (C-2′), 126.1 (C-12), 105.9 (GlcA C-1), 103.0 (Glc C-1), 102.7 (Rha C-1), 101.5 (Gal C-1), 92.1 (C-3), 82.7 (GlcA C-6), 79.7 (GlcA C-2), 78.8 (Glc C-5), 78.5 (Gal C-5), 77.7 (Glc C-3), 76.8 (Gal C-2), 76.7 (Glc C-2), 76.0 (GlcA C-5), 75.4 (C-16), 75.2 (Gal C-4), 74.6 (Rha C-4), 73.2 (C-22), 73.2 (Rha C-2), 72.7 (Glc C-4), 72.1 (Gal C-3), 71.4 (GlcA C-4), 71.4 (Rha C-3), 70.8 (Rha C-5), 68.4 (C-15), 63.7 (C-28), 63.7 (Glc C-6), 62.7 (Gal C-6), 56.5 (C-5), 49.5 (C-14), 49.0 (C-19), 47.8 (C-9), 47.6 (C-19), 45.5 (C-17), 42.3 (C-18), 42.1 (C-8), 41.7 (C-21), 40.2 (C-1), 40.0 (C-1), 37.7 (C-10), 37.0 (C-7), 33.4 (C-29), 32.3 (C-20), 28.2 (C-23), 26.9 (C-2), 25.6 (C-27), 25.12 (C-30), 24.6 (C-11), 20.7 (C-27), 19.4 (C-6), 17.7 (Rha C-6), 17.6 (C-26), 16.1 (C-24), 15.7 (C-25).
Naringin (16): yellow powder, HRESIMS m/z 579.1883 [M − H]− (calcd. for C27H32O14); 1H NMR (500 MHz, methanol-d4) δH 7.29 (2H, d, J = 8.6 Hz, H-2′, 6′), 6.80 (2H, d, J = 8.6 Hz, H-3′, 5′), 6.15 (1H, d, J = 2.3 Hz, H-8), 6.13 (1H, d, J = 2.2 Hz, H-6), 5.34 (1H, dd, J = 13.0, 2.6 Hz, H-2), 5.23 (1H, dd, J = 5.1, 1.7 Hz, Rha, H-1), 5.07 (1H, dd, J = 9.1, 7.5 Hz, Glc, H-1), 3.94–3.32 (10H, m, Sugar-H), 3.19–3.08 (1H, m, H-3), 2.77–2.67 (1H, m, H-3), 1.27 (3H, d, J = 6.2 Hz, Me). 13C NMR (126 MHz, methanol-d4) δC 198.8 (C-4), 166.7 (C-7), 165.1 (C-5), 164.8 (C-5), 164.8 (C-9), 159.3 (C-4′), 130.9 (C-1′), 129.4 (C-2′, 6′), 116.5 (C-3′, 5′), 105.1 (C-10), 102.7 (Glc, C-1), 99.5 (Rha, C-1), 98.0 (C-6), 96.9 (C-8), 80.8 (C-2), 79.3 (Glc, C-2), 79.1 (Glc, C-3), 78.3 (Glc, C-5), 74.1 (Rha, C-4), 72.3 (Rha, C-2), 72.3 (Rha, C-3), 71.4 (Glc, C-4), 70.2 (Rha, C-5), 62.4 (Glc, C-6), 44.0 (C-3), 18.4 (Rha, C-6).
Icario A2 (17): pale yellow powder, HRESIMS m/z 435.1645 [M − H]− (calcd. for C22H28O9); 1H NMR (500 MHz, methanol-d4) δH 6.76 (4H, s, H-2, 2′, 6, 6′), 4.97 (1H, d, J = 8.5 Hz, H-7, 7′), 3.88 (12H, s, H-3, 3′, 5, 5′-OMe), 3.73–3.65 (4H, m, H-9, 9′), 2.36–2.28 (2H, m, H-8, 8′). 13C NMR (126 MHz, methanol-d4) δC 149.3 (C-3, 3′, 5, 5′), 136.2 (C-4, 4′), 134.3 (C-1, 1′), 104.9 (C-2, 2′, 6, 6′), 84.6 (C-7, 7′), 61.69 (C-9, 9′), 56.8 (-OMe), 55.2 (C-8, 8′).

2.6. Antioxidant Activity

2.6.1. DPPH Assay

For determining the DPPH free radical-scavenging activities of the EtOAc extract of C. fascicularis, different fractions were assessed according to the method described by Jiang et al. [34]. The concentration gradient of the EtOAc extract and the different fractions was 0.01–10.0 mg/mL, and the concentration gradient of VC was 5–30 µg/mL. Initially, the samples were dissolved in DMSO to different concentrations, and the DPPH was dissolved in PBS (0.1 M, pH 6.8) to 0.1 mM. Then, 300 µL DPPH solution and 300 µL sample were mixed in each well of a 2 mL Eppendorf (EP) tube well plate and incubated for 30 min at room temperature in the dark. The absorbance was measured using a microplate reader at 517 nm, and ascorbic acid was used as a positive control. All tests were performed in triplicate, and the obtained results were processed by analysis of variance (ANOVA) with 95% confidence (p ≤ 0.05). Results are expressed as half-maximal inhibitory concentration (IC50).
The percentage radical scavenging rate (%) of each test sample for DPPH was calculated as follows (1):
Radical scavenging rate (%) = [Ablank − (Asample − Acontrol)]/Ablank × 100%

2.6.2. ABTS Assay

The ABTS free radical-scavenging capacity of all isolated compounds was measured using a previous method with minor modifications [35]. The experiment was conducted using a 96-well plate, and each well had a total volume of 210 µL. Equal volumes of ABTS solution (7 mM) and potassium persulfate solution (5 mM) were mixed evenly and left to react at room temperature for 12 h in the dark to obtain the ABTS radical cation. The mixture was then diluted with anhydrous methanol to achieve an absorbance value of about 0.7 ± 0.02 units at 734 nm. Then, 180 µL of ABTS working solution was added to each well, followed by 30 µL samples of varying concentrations (0.01–10.0 mg/mL) that were dissolved and diluted with DMSO. After mixing well, the samples were incubated at room temperature for 6 min away from light. After that, the absorbance values of each well were measured at 734 nm using a microplate reader, and the results were obtained from a minimum of three independent experiments. Ascorbic acid was used as the positive control. DMSO was used to replace the sample solution as a blank, and absolute methanol was used to replace the ABTS solution as a control. All tests were performed in triplicate, and the obtained results were processed by ANOVA with 95% confidence (p ≤ 0.05). Results are expressed as IC50.
The percentage radical cation-scavenging rate (%) of each test sample for ABTS was calculated as follows (2):
Radical cation-scavenging rate (%) = [Ablank − (Asample − Acontrol)]/Ablank × 100%

2.6.3. Ferric Ion-Reducing Antioxidant Power (FRAP) Assay

The FRAP of all isolated compounds was measured using a slightly modified methodology [36]. The acetate buffer (0.3 M, pH 3.6), TPTZ (2,4,6-tris(2-pyridyl)-S-triazine) solution (10 mM) in 40 mM HCl, and ferric chloride aqueous solution (20 mM) were uniformly mixed in a volume ratio of 10:1:1 to obtain the FRAP working solution. The FRAP reserve is pre-warmed for 10 min at 37 °C in a constant temperature water bath before use. The experiment was started in an EP tube for the reaction. Then, 2 mL of FRAP working solution was added to each well, followed by 150 µL of sample solution 0.5 mg/mL. Then, the mixture was stirred well and left to react at room temperature for 30 min. Then, 200 µL of the reaction solution was added into the 96-well plate. The absorbance values of each well were measured at 593 nm using a microplate reader, and the results were obtained from at least three independent experiments. The sample solution was replaced with DMSO as a blank solution, and ascorbic acid was used as a positive control, which results in absorbance.

2.7. Antimicrobial Activity

The antibacterial activity capacity of all isolated compounds was measured using a previous method with minor modifications [37,38]. Antibacterial compound solution composition: dissolve the drug in DMSO such that its mass concentration was 0.5 mg/mL. Preparation of the bacterial solution for testing: remove the frozen bacteria from the −80 °C low-temperature storage box to thaw at room temperature, and Nutrient Broth (NB) medium sterilised at 37 °C in a shaking bed was used for the overnight culture. Then, 2 mL of the overnight culture was taken and inoculated into NB medium, incubated at 37 °C until A600 = 0.5, diluted 100 times with NB medium, and set aside. Microdilution method: a sterile 96-well plate was taken, 75 μL of NB medium dilution solution was added to A2–A11 wells, and 75 μL of compound solution was added to A1–A2 wells. After gradient dilution from A2, an 8-channel pipette was used to pipette 75 μL of each compound dilution into a 96-well plate so that the final concentration of compounds in the 96-well plate was in the range of 500 to 1.95 µg/mL. The inoculated 96-well plates were incubated at 37 °C for 12 h. After inoculation, the 96-well plates were incubated at 37 °C for 16 h to observe the growth, and the minimum inhibitory concentration (MIC) was calculated by measuring A600 with an enzyme marker. All tests were performed in triplicate, and the obtained results were processed by ANOVA with 95% confidence (p ≤ 0.05).

3. Results and Discussion

3.1. Antioxidant Activity of the EtOAc Extract and Fr. (A–I)

Oxidative stress (OS) refers to the imbalance between oxidation and antioxidation in the body. Studies have found that oxidative stress is related to a variety of diseases, such as cardiovascular diseases, diabetes, and metabolic disorders [39]. Therefore, the EtOAc extract and Fr. (A–I) of C. fascicularis were evaluated for their antioxidant activities using DPPH, ABTS, and FRAP assays to obtain their IC50 concentrations. As shown in Table 2, the EtOAc extract had antioxidant activity. This result supported the benefits of using C. fascicularis in herbs and food. Furthermore, in the DPPH and ABTS tests, we found that the EtOAc extract and the different fractions were capable of scavenging DPPH and ABTS free radicals in a concentration-dependent manner. The results showed that the DPPH free radical-scavenging ability was D > F> A > G > E > B* > I > H, the ABTS free radical-scavenging ability was D > B* > E > F > A > I > G > H, the FRAP free radical-scavenging ability was D > B* > E > A > F > G > I > H, and the scavenging capacity of DPPH and ABTS was related to the accumulative effect of fractions. DPPH, ABTS, and FRAP assays showed that the antioxidant activity of Fr. (A–F) had obvious antioxidant activity, Fr. (G) had moderate antioxidant activity, and Fr. (H–I) had no significant antioxidant activity. The results suggested that the main antioxidant compounds of the EtOAc extract of C. fascicularis might be present in the Fr. (A–G).
DPPH, ABTS, and FRAP assays also showed some differences in the experimental results, which may be attributed to the different mechanisms of scavenging free radicals. The main pathway of scavenging free radicals is through the transfer of electrons from the antioxidant or the transfer of hydrogen to the free radicals [40]. ABTS can scavenge through the transfer of both electrons and hydrogen, whereas the scavenging of free radicals by DPPH is mainly through the transfer of hydrogen to the free radicals through the antioxidant, and this effect dominates only in strong hydrogen-bonding solvents such as methanol. DPPH scavenges free radicals mainly by transferring hydrogen from the antioxidant to the free radicals, and electron transfer is dominant only in strongly hydrogen-bonded solvents such as methanol [41].

3.2. Antimicrobial Activities of the EtOAc Extract and Fr. (A–I)

The application of plant extracts as natural antimicrobial agents in the food industry is a growing trend [42]. The antimicrobial activity testing of the samples was performed against microorganism strains from the laboratory collection. The Gram-positive bacteria used for the tests were Staphylococcus aureus (ATCC 6538). The Gram-negative bacteria were Escherichia coli (ATCC 6538) and Pseudomonas aeruginosa (CGMCC 1.10712). The antimicrobial activity of C. fascicularis has not been reported thus far, but the antimicrobial activity of Camellia has been proven, and Camellia has good antimicrobial activity [43,44,45]. The findings provide additional evidence to support the high antibacterial activity of secondary metabolites derived from C. fascicularis. Therefore, the EtOAc extract and Fr. (A–I) of C. fascicularis were evaluated for their antimicrobial activity according to microbroth dilution method and MIC. The concentration of the EtOAc extract and the different fractions was 20 mg/mL.
As shown in Table 3, the MICs of the EtOAc extract against E. coli, S. aureus, and P. aeruginosa were all greater than 20 mg/mL. Fr. (E–F, I) showed good inhibition of E. coli (MIC 20 mg/mL), Fr. (E, G–I) showed good inhibition of S. aureus (MIC 20 mg/mL), and Fr. (D–E, H–I) showed good inhibition of P. aeruginosa (MIC: 10 mg/mL). However, as a whole, the EtOAc extract and the different fractions had a higher inhibitory effect on P. aeruginosa than on E. coli and S. aureus. Fr. (D–I) is the fraction of the EtOAc extract of C. fascicularis with antibacterial activity. It is more interesting to note that Fr. (D–G) has not only good antioxidant activity, but also its antimicrobial activity is also prominent, which may be related to the active components such as phenolic acids, flavonoids, lignans, terpenoids, etc. [46,47,48]. However, Fr. (H–I) has poor antioxidant activity and prominent antimicrobial activity, suggesting that there may be secondary metabolites in this fraction that are worthy of further exploration.

3.3. Antioxidant Activity of the Compounds

In the ABTS assay, the antioxidant activity is measured as the ability of test compounds to decrease the colour by reacting directly with the radical ABTS [49]. Methods such as the ABTS assay were used to evaluate antioxidant activities of all the isolates in vitro, and the results are shown in Table 4. The results of these experiments showed that compounds 1, 3, 9, 11, and 17 exhibited higher antioxidant activity than the positive control drug, ascorbic acid, and the antioxidant activity of compounds 4, 8, 10, and 13 was slightly lower than that of ascorbic acid. The other compounds had weaker or no significant antioxidant activities. This is also the first report of antioxidant activity of compounds 4–7, 13–15, and 17. This finding once again confirms that flavonoids [50,51,52], lignans [53,54,55], and phenolic acid [56] compounds have good antioxidant activities.
The compounds 1, 3–4, and 14 are phenolics; however, compounds 1, 3–4, and 14 are phenolic acids with hydroxybenzoic acid as the parent compound, and compound 4 has significantly lower antioxidant activity than compounds 1–3 and 14, and the introduction of O-hydroxy and O-methoxy groups promotes the antioxidant activity of phenolic acids [57]. Compound 2 has no active site in its structure, which contributes to its poor antioxidant activity. Compounds 5–7, 12, and 15 are terpenoids, and compounds 5–7 are β-ionone derivatives, which have certain antioxidant activity and may be the unique aromatic component of C. fascicularis. Meanwhile, the development of β-ionone derivatives of curcuminoids can be prioritised by the substitution of meso and neighbouring substituent derivatives and the replacement of benzene’s second substituent group, so as to obtain a better biological activity. Compounds 12 and 17 are triterpenoids, but the antioxidant activity of compound 17 was significantly lower than that of compound 12, probably due to the introduction of the sugar group and the substitution of the active site to reduce the activity of the compounds.
Compound 9 exhibits significantly higher antioxidant activity compared to compounds 8 and 10. An analysis of the structure–activity relationship for these three flavonoids shows that the free radical-scavenging activity is directly correlated with the number of hydroxyl groups on the B ring. An increase in the number of hydroxyl groups on the B ring leads to enhanced free radical-scavenging activity. Additionally, it is worth noting that C-3 possesses an alcohol hydroxyl group that demonstrates greater stability and reduced susceptibility to electron loss when compared to a phenolic hydroxyl group. This characteristic contributes to the increased water solubility of compounds without significantly impacting their antioxidant activity. These findings are consistent with previous analyses of the literature on the relationship between the antioxidant activities and conformations of flavonoids [58,59,60]. Meanwhile, there were differences in the antioxidant activities of compounds 8, 9, and 16, which were mainly related to the number and position of hydroxyl groups and the spatial site resistance of the glycosides [61]. The large difference in the antioxidant activity of compounds 13 and 17 may be due to the presence of methoxy in the neighbourhood of the phenolic hydroxyl group to provide power, which positively affects the antioxidant activity of lignans [62]. Compound 13 may be the main component of C. fascicularis, giving rise to its bitter flavour [63]. This suggests that flavonoids, phenols, lignans, and terpenoids are the major antioxidant secondary metabolites in C. fascicularis.

3.4. Antibacterial Activity of the Compounds

Most of the compounds with antimicrobial activity in plants are plant secondary metabolites, and the most abundant species can be divided into polysaccharides, phenols, alkaloids, terpenoids, etc., and their rich variety and diverse chemical structures can produce antimicrobial activity through a variety of pathways, and the main antimicrobial mechanisms include the disruption of the cellular structure, regulation of gene expression, inhibition of bacterial metabolic activity, and alteration in the cell membrane potential [64,65].
As shown in Table 5, the results of the antimicrobial activity test showed that compounds 1–17 inhibited E. coli to a certain extent at a concentration of 500 µg/mL, among which the antimicrobial activity of compound 11 was lower than that of other compounds. Compounds 1–3 and 5–11 showed some degree of inhibition against S. aureus at 250–500 µg/mL, and among them, compound 12 showed better antibacterial activity than the other compounds, but this activity was still weaker compared to that of the positive control drug. The antibacterial activity of compounds 4, 7, and 11–12 against P. aeruginosa was comparable to that of the positive control drug tetracycline (MIC: 125.00 µg/mL) and superior to that of penicillin (MIC: 250.00 ug/mL), whereas the antibacterial activity of compounds 1, 3, 5–6, 8–10, and 14–17 against P. aeruginosa was comparable to that of the positive control drug penicillin (MIC: 250.00 µg/mL) and weaker than that of penicillin (MIC: 250.00 µg/mL) and tetracycline (MIC: 125.00 µg/mL). Polyphenols play an important role in plants and are an important material basis for protecting plants from foreign invasion and injury such as those caused by parasites and pathogenic bacteria [66]. It has been shown that the increase in rhamnose content in the analysed plants improves the antimicrobial properties of the polysaccharides, which may also be the reason for the antimicrobial activity of compound 15 to some degree [67]. Usually ring-forming monoterpenes are more active than acyclic ones, and different substituents produce different effects on the antimicrobial activity of terpenoids [68]. This suggests that flavonoids, phenolics, and terpenoids are the main secondary metabolites producing the antimicrobial activity of C. fascicularis. The antimicrobial effects of compounds 1–17 were essentially consistent with the those observed in the antimicrobial-directed activity screening, and they inhibited P. aeruginosa better compared to E. coli and S. aureus.

4. Conclusions

The secondary metabolites of the leaves of C. fascicularis were investigated. The results of bioactivity-guided isolation indicated that the major antioxidant compounds in the ethanolic extracts of C. fascicularis may be present in C. fascicularis Fr. (A–G). Fr. (D–I) is a fraction of C. fascicularis with antimicrobial activity, containing 17 compounds, including fours phenolics (1,3–4, 14), a phenylpropane (2), five terpenoids (5–7, 12, 15), four flavonoids and flavonoid glycosides (8–10, 16), and two lignins (13, 17). Compounds 4–7, 13–15, and 17 were isolated from the genus Camellia for the first time. The remaining compounds were also isolated from C. fascicularis for the first time. This is also the first report of the antioxidant and antimicrobial activities of compounds 5–7, 13–15, and 17. The antioxidant and antimicrobial activities of the isolated and obtained compounds were determined. These activities suggest that flavonoids, phenols, lignans, and terpenoids are the main secondary metabolites that produce the antioxidant and antibacterial activities of C. fascicularis. The results of the study enriched the variety of secondary metabolites of C. fascicularis, laid the foundation for further research on the pharmacological efficacy and biological activity of this plant, and provided reference and theoretical basis for the development and utilisation of this plant resource.

Author Contributions

Conceptualization, R.L., J.T. (Jiandong Tang), and W.W.; methodology, R.L., J.T. (Jiandong Tang), and J.L.; software, R.L. and J.T. (Jiandong Tang); validation, B.W., J.T. (Junrong Tang), and H.K.; formal analysis, J.L. and B.W.; investigation, Y.Z. and P.Z.; resources, Y.L and P.Z.; data curation, R.L. and J.T. (Jiandong Tang); writing—original draft preparation, R.L., J.T. (Jiandong Tang), and W.W.; writing—review and editing, W.W. and Y.L.; visualization, R.L. and J.T. (Jiandong Tang); supervision, P.Z. and W.W.; project administration, Y.L.; funding acquisition, Y.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Yunnan Agricultural Basic Research Joint Special Project (202101BD070001-045) and Youth Talents Special Project of Yunnan Province “Xingdian Talents Support Program” (XDYC-QNRC-2022-0222).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Liu, Y.; Luo, X.L.; Lan, Z.Q.; Tang, J.R.; Zhao, P.; Kan, H. Ultrasonic-assisted extraction and antioxidant capacities of flavonoids from Camellia fascicularis leaves. CyTA-J. Food. 2018, 16, 105–112. [Google Scholar] [CrossRef]
  2. Hu, X.; Tang, J.R.; Zhang, G.L.; Deng, J.; Kan, H.; Zhang, Y.J.; Zhao, P.; Liu, Y. Optimization of extraction process and antioxidant activities of saponins from Camellia fascicularis leaves. J. Food Meas. Charact. 2021, 15, 1889–1898. [Google Scholar] [CrossRef]
  3. Liu, Y.; Kan, H.; Fang, F.Y.; Tang, J.R.; Zhang, Y.J.; Zhao, P. Microwave-assisted extraction and antioxidant activities of polyphenols from Camellia fascicularis leaves. Curr. Top. Nutraceut. Res. 2019, 17, 164–171. [Google Scholar]
  4. Song, L.X.; Wang, X.S.; Zheng, X.Q.; Huang, D.J. Polyphenolic antioxidant profiles of yellow camellia. Food Chem. 2011, 129, 351–357. [Google Scholar] [CrossRef] [PubMed]
  5. Peng, X.; Yu, D.Y.; Feng, B.M.; Wang, Y.Q.; Shi, L.Y. A new acylated flavonoid glycoside from the flowers of Camellia nitidissima and its effect on the induction of apoptosis in human lymphoma U937 cells. J. Asian. Nat. Prod. Res. 2012, 14, 799–804. [Google Scholar] [CrossRef] [PubMed]
  6. Gao, D.F.; Xu, M.; Zhao, P.; Zhang, X.Y.; Wang, Y.F.; Yang, C.R.; Zhang, Y.J. Kaempferol acetylated glycosides from the seed cake of Camellia oleifera. Food Chem. 2011, 124, 432–436. [Google Scholar] [CrossRef]
  7. Chen, J.H.; Wu, X.H. Extraction process optimization of saponin from the leaves of Camellia nitidissima Chi and its inhibition of lipase activity. Food Mach. 2020, 36, 159–165. [Google Scholar] [CrossRef]
  8. Peng, X.; Yu, D.Y.; Feng, B.M.; Tang, L.; Wang, Y.Q.; Shi, L.Y. Chemical constituents from the flowers of Camellia chrysantha. Guihaia 2011, 31, 550–553. [Google Scholar] [CrossRef]
  9. He, X.H.; Shi, Z.J.; Peng, X.W.; Kan, H.; Zhao, P.; Liu, Y. Antioxidant activities analysis of different polar solvent extracts from Camellia fascicularis H T. Chang. Chem. Ind. For. Prod. 2022, 42, 61–68. [Google Scholar]
  10. Peng, X.W.; He, X.H.; Tang, J.R.; Xiang, J.Y.; Deng, J.; Kan, H.; Zhang, Y.J.; Zhang, G.L.; Zhao, P.; Liu, Y. Evaluation of the in vitro antioxidant and antitumor activity of extracts from Camellia fascicularis leaves. Front. Chem. 2022, 10, 1035949. [Google Scholar] [CrossRef]
  11. Peng, X.W.; Hu, X.; Zhang, Y.J.; Xu, H.; Tang, J.R.; Zhang, G.L.; Deng, J.; Kan, H.; Zhao, P.; Liu, Y. Extraction, characterization, antioxidant and anti-tumor activities of polysaccharides from Camellia fascicularis leaves. Int. J. Biol. Macromol. 2022, 222, 373–384. [Google Scholar] [CrossRef] [PubMed]
  12. Gao, M.Z.; Peng, X.W.; Tang, J.R.; Deng, J.; Wang, F.; Zhang, Y.J.; Zhao, P.; Kan, H.; Liu, Y. Anti-inflammatory effects of Camellia fascicularis polyphenols via attenuation of NF-κB and MAPK pathways in LPS-induced THP-1 macrophages. J. Iinflamm. Res. 2022, 15, 851–864. [Google Scholar] [CrossRef] [PubMed]
  13. Gao, M.Z.; Tang, J.R.; Deng, J.; Xiang, J.Y.; Kan, H.; Zhao, P.; Zhang, Y.J.; Zhang, G.L.; Liu, Y. Evaluation of anti-inflammatory effect of Camellia fascicularis polyphenols using zebrafish model and network pharmacology. Food Sci. 2023, 44, 134–142. [Google Scholar] [CrossRef]
  14. Takahashi, J.A.; Gomes, D.C.; Lyra, F.H.; Santos, G.F.; Martins, L.R. The remarkable structural diversity achieved in ent-kaurane diterpenes by fungal biotransformation. Molecules 2014, 19, 1856–1886. [Google Scholar] [CrossRef] [PubMed]
  15. Shi, Q.W.; Li, L.G.; Huo, C.H.; Zhang, M.L.; Wan, Y.F. Study on natural medicinal chemistry and new drug development. Chin. Traditl. Herb. Drugs. 2010, 41, 1583–1589. [Google Scholar]
  16. Chen, Y.H.; Chen, Q.W.; Wang, X.Z.; Sun, F.; Fan, Y.W.; Liu, X.R.; Li, H.Y.; Deng, Z.Y. Hemostatic action of lotus leaf charcoal is probably due to transformation of flavonol aglycons from flavanols glycosides in traditional Chinses medicine. J. Ethnopharmacol. 2020, 249, 112364. [Google Scholar] [CrossRef] [PubMed]
  17. Tang, J.D.; Li, R.L.; Wu, B.X.; Tang, J.R.; Kan, H.; Zhao, P.; Zhang, Y.J.; Wang, W.H.; Liu, Y. Secondary metabolites with antioxidant and antimicrobial activities from Camellia fascicularis. Curr. Issues Mol. Biol. 2024, 6, 6769–6782. [Google Scholar] [CrossRef]
  18. Yuan, T.; Hwang, I.H.; Na, M. Chemical constituents of Mallotus japonicus thunb. and their chemotaxonomic significance. Biochem. Syst. Ecol. 2024, 113, 104801. [Google Scholar] [CrossRef]
  19. Ren, L.; Wang, Y.Z.; Zhang, W.; Zhou, R.; Zhao, M.; Tang, Z.S.; Zhang, D.B. Triculata A, a novel compound from Tricyrtis maculata (D. Don) JF macbr. with biological properties. Nat. Prod. Res. 2021, 35, 3729–3737. [Google Scholar] [CrossRef]
  20. Xu, Y.; Liang, X.H.; Hyun, C.G. Isolation, characterization, genome annotation, and evaluation of tyrosinase inhibitory activity in secondary metabolites of Paenibacillu sp. JNUCC32: A comprehensive analysis through molecular docking and molecular dynamics simulation. Int. J. Mol. Sci. 2024, 25, 2213. [Google Scholar] [CrossRef]
  21. Li, M.X.; Xie, J.; Bai, X.; Du, Z.Z. Anti-aging potential, anti-tyrosinase and antibacterial activities of extracts and compounds isolated from Rosa chinensis cv. ‘JinBian’. Ind. Crop. Prod. 2021, 159, 113059. [Google Scholar] [CrossRef]
  22. Pan, R.Y.; Sun, Y.J.; Chen, H.J.; Li, M.; Si, Y.Y.; Feng, W.S. Terpenoids and alkaloids from Cissampelos pareira var. hirsuta. Chin. Traditl. Herb. Drugs 2022, 53, 5607–5612. [Google Scholar] [CrossRef]
  23. Zhou, J.; Li, G.; Deng, Q.; Zheng, D.Y.; Yang, X.B.; Xu, J. Cytotoxic constituents from the mangrove endophytic Pestalotiopsis sp. induce G0/G1 cell cycle arrest and apoptosis in human cancer cells. Nat. Prod. Res. 2018, 32, 2968–2972. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, Y.L.; Zheng, Y.; Shi, W.; Guo, Y.; Xu, T.; Li, Z.; Huang, C.; Li, J. Design, Synthesis and investigation of the potential anti-inflammatory activity of 7-O-amide hesperetin derivatives. Molecules 2019, 24, 3663. [Google Scholar] [CrossRef] [PubMed]
  25. Shen, Z.J.; Chen, F.L.; Jia, C.Y.; Li, D.S.; Zhang, Q.Z.; Li, W.X.; Wang, W.J. Flavonoids from the pericarp of Tamarindus indica Linn. and their antioxidant activity. Nat. Prod. Res. Dev. 2024, 35, 1877–1886. [Google Scholar] [CrossRef]
  26. Jia, Y.P.; Yang, X.J.; Wang, C.; Ren, H.B.; Hu, X.J.; Yang, H.Z. Chemical constituents from roots of Bupleurum chinense. Chin. Traditl. Herb. Drugs 2024, 55, 402–408. [Google Scholar]
  27. Kamso, V.F.K.; Simo Fotso, C.C.; Kanko Mbekou, I.M.; Tousssie, B.T.; Ndjakou Lenta, B.; Boyom, F.F.; Sewald, N.; Frese, M.; Ngadjui, B.T.; Wabo Fotso, G. Chemical constituents of Macaranga occidentalis, antimicrobial and chemophenetic studies. Molecules 2022, 27, 8820. [Google Scholar] [CrossRef] [PubMed]
  28. Chen, J.K.; Ge, Z.Y.; Liao, X.W.; Xue, J.; Wu, L.; Liang, L.F. α-Glucosidase inhibitory phytochemical components of chinese endemic pant Whitfordiodendron filipes var. tomentosum. Plants 2024, 13, 692. [Google Scholar] [CrossRef]
  29. Ouyang, F.; Yuan, L.; Liu, Y.; Li, R.; Li, L.; Wang, N.L.; Yao, X.S. Five lignans and an iridoid from Sambucus williamsii. Chin. J. Nat. Med. 2011, 9, 26–29. [Google Scholar] [CrossRef]
  30. Wang, Y.F.; Li, S.W.; He, R.J.; Yang, B.Y.; Huang, Y.L. Study on the chemical composition and tyrosinase inhibitory activity of Castanopsis ceratacantha. Nat. Prod. Res. Dev. 2021, 33, 1499–1505. [Google Scholar]
  31. Ohtsuki, T.; Miyagawa, T.; Koyano, T.; Kowithayakorn, T.; Kawahara, N.; Goda, Y.; Ishibashi, M. Acylated triterpenoid saponins from Schima noronhae and their cell growth inhibitory activity. J. Nat. Prod. 2008, 71, 918–921. [Google Scholar] [CrossRef]
  32. Hao, K.X.; Shen, C.Y.; He, M.X.; Jiang, J.G.; Wang, D.W.; Zhu, W. Comparative activities of three compounds from Citrus aurantium L. var. amara engl. to Improve oxidized low-density lipoprotein induced lipid deposition. ACS Omega 2024, 9, 5683–5694. [Google Scholar] [CrossRef]
  33. Gan, J.; Wei, W.; Tan, J.N.; Shen, M.N.; Tan, Q.G. The NO inhibitory constituents from Illigera rhodantha. Acta Pharm. Sin. 2022, 57, 1849–1854. [Google Scholar]
  34. Jiang, W.; Zhou, X. Hydrolysis of radish anthocyanins to enhance the antioxidant and antiproliferative capacities. Food Chem. 2019, 294, 477–485. [Google Scholar] [CrossRef]
  35. Wang, Z.B.; Pei, J.J.; Ma, H.L.; Cai, P.F.; Yan, J.K. Effect of extraction media on preliminary characterizations and antioxidant activities of Phellinus linteus polysaccharides. Carbohyd. Polym. 2014, 109, 49–55. [Google Scholar] [CrossRef]
  36. Luo, J.G.; Li, L.; Kong, L.Y. Preparative separation of phenylpropenoid glycerides from the bulbs of Lilium lancifolium by high-speed counter-current chromatography and evaluation of their antioxidant activities. Food Chem. 2012, 131, 1056–1062. [Google Scholar] [CrossRef]
  37. Rivero-Cruz, J.F.; Granados-Pineda, J.; Pedraza-Chaverri, J.; Perez-Rojas, J.M.; Kumar-Passari, A.; Diaz-Ruiz, G.; Rivero-Cruz, B.E. Phytochemical constituents, antioxidant, cytotoxic, and antimicrobial activities of the ethanolic extract of Mexican Brown Propolis. Antioxidants 2020, 9, 70. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, Y.J.; Huang, J.M.; Wen, C.; Zhou, Z.S.; Feng, C.C.; Hu, C.H.; Zhou, P.F.; Yin, G.P. Chemical constituents from whole herb of Hedyotis scandens. China J. Chin. Mater. Med. 2023, 48, 6082–6087. [Google Scholar] [CrossRef]
  39. Balakrishnan, B.; Paramasivam, S.; Arulkumar, A. Evaluation of the lemongrass plant (Cymbopogon citratus) extracted in different solvents for antioxidant and antibacterial activity against human pathogens. Asian Pac. J. Trop. Dis. 2014, 4, S134–S139. [Google Scholar] [CrossRef]
  40. Tian, X.; Schaich, K.M. Effects of molecular structure on kinetics and dynamics of the trolox equivalent antioxidant capacity assay with ABTS+. J. Agric. Food Chem. 2013, 61, 5511–5519. [Google Scholar] [CrossRef] [PubMed]
  41. Schaich, K.M.; Tian, X.; Xie, J. Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays. J. Funct. Foods 2015, 14, 111–125. [Google Scholar] [CrossRef]
  42. Soltan, O.I.A.; Gazwi, H.S.S.; Ragab, A.E.; Aljohani, A.S.M.; El-Ashmawy, I.M.; Batiha, G.E.S.; Hafiz, A.A.; Abdel-Hameed, S.M. Assessment of bioactive phytochemicals and utilization of Rosa canina fruit extract as a novel natural antioxidant for mayonnaise. Molecules 2023, 28, 3350. [Google Scholar] [CrossRef] [PubMed]
  43. Zhao, Y.; Su, R.Q.; Zhang, W.T.; Yao, G.L.; Chen, J. Antibacterial activity of tea saponin from Camellia oleifera shell by novel extraction method. Ind. Crop. Prod. 2020, 153, 112604. [Google Scholar] [CrossRef]
  44. Goulas, V.; Exarchou, V.; Kanetis, L.; Gerothanassis, I.P. Evaluation of the phytochemical content, antioxidant activity and antimicrobial properties of mountain tea (Sideritis syriaca) decoction. J. Funct. Foods 2014, 6, 248–258. [Google Scholar] [CrossRef]
  45. Keller, A.C.; Weir, L.T.; Broeckling, D.C.; Ryan, E.P. Antibacterial activity and phytochemical profile of fermented Camellia sinensis (fuzhuan tea). Food Res. Int. 2013, 53, 945–949. [Google Scholar] [CrossRef]
  46. Tian, Y.; Puganen, A.; Alakomi, H.L.; Uusitupa, A.; Saarela, M.; Yang, B. Antioxidative and antibacterial activities of aqueous ethanol extracts of berries, leaves, and branches of berry plants. Food Res. Int. 2018, 106, 291–303. [Google Scholar] [CrossRef] [PubMed]
  47. Yaermaimaiti, S.; Wu, T.; Aisa, H.A. Bioassay-guided isolation of antioxidant, antimicrobial, and antiviral constituents of Cordia dichotoma fruits. Ind. Crop. Prod. 2021, 172, 113977. [Google Scholar] [CrossRef]
  48. Shamsudin, N.F.; Ahmed, Q.U.; Mahmood, S.; Ali Shah, S.A.; Khatib, A.; Mukhtar, S.; Alsharif, M.A.; Parveen, H.; Zakaria, Z.A. Antibacterial effects of flavonoids and their structure-activity relationship study: A comparative interpretation. Molecules 2022, 27, 1149. [Google Scholar] [CrossRef] [PubMed]
  49. Prior, R.L.; Wu, X.; Schaich, K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J. Agric. Food Chem. 2005, 53, 4290–4302. [Google Scholar] [CrossRef] [PubMed]
  50. Xu, H.; Yu, S.L.; Lin, C.X.; Dong, D.J.; Xiao, J.B.; Ye, Y.B.; Wang, M.F. Roles of flavonoids in ischemic heart disease: Cardioprotective effects and mechanisms against myocardial ischemia and reperfusion injury. Phytomedicine 2024, 126, 155409. [Google Scholar] [CrossRef]
  51. Li, H.; Lin, J.; Bai, B.; Bo, T.; He, Y.; Fan, S.; Zhang, J. Study on purification, identification and antioxidant of flavonoids extracted from Perilla leaves. Molecules 2023, 28, 7273. [Google Scholar] [CrossRef]
  52. Xi, J.; Yan, L.L. Optimization of pressure-enhanced solid-liquid extraction of flavonoids from Flos Sophorae and evaluation of their antioxidant activity. Sep. Purif. Technol. 2017, 175, 170–176. [Google Scholar] [CrossRef]
  53. Jang, W.Y.; Kim, M.Y.; Cho, J.Y. Antioxidant, anti-inflammatory, anti-menopausal, and anti-cancer effects of lignans and their metabolites. Int. J. Mol. Sci. 2022, 23, 15482. [Google Scholar] [CrossRef] [PubMed]
  54. Ul’yanovskii, N.V.; Onuchina, A.A.; Faleva, A.V.; Gorbova, N.S.; Kosyakov, D.S. Comprehensive characterization of chemical composition and antioxidant activity of lignan-rich coniferous knotwood extractives. Antioxidants 2022, 11, 2338. [Google Scholar] [CrossRef] [PubMed]
  55. Vek, V.; Keržič, E.; Poljanšek, I.; Eklund, P.; Humar, M.; Oven, P. Wood extractives of silver fir and their antioxidant and antifungal properties. Molecules 2021, 26, 6412. [Google Scholar] [CrossRef] [PubMed]
  56. Zhang, M.; Shuai, X.X.; Wei, Z.; Dai, T.T.; Wei, C.B.; Li, Y.; He, J.J.; Du, L.Q. Characterization, antioxidant and antitumor activities of phenolic compounds from Amomum villosum Lour. Front. Nutr. 2024, 11, 1327164. [Google Scholar] [CrossRef] [PubMed]
  57. Chen, J.X.; Yang, J.; Ma, L.L.; Li, J.; Shahzad, N.; Kim, C.K. Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Sci. Rep. 2020, 10, 2611. [Google Scholar] [CrossRef]
  58. Li, K.; Fan, H.; Yin, P.P.; Yang, L.G.; Xue, Q.; Li, X.; Sun, L.W.; Liu, Y.J. Structure-activity relationship of eight high content flavonoids analyzed with a preliminary assign-score method and their contribution to antioxidant ability of flavonoids-rich extract from Scutellaria baicalensis shoots. Arab. J. Chem. 2018, 11, 159–170. [Google Scholar] [CrossRef]
  59. Zhang, Q.; Yang, W.B.; Liu, J.C.; Liu, H.; Zhang, C.L.; Chen, D.L.; Jian, Z.G. Identification of six flavonoids as novel cellular antioxidants and their structure-activity relationship. Oxid. Med. Cell. Longev. 2020, 2020, 4150897. [Google Scholar] [CrossRef] [PubMed]
  60. Yang, T.; Zhang, Z.; Ning, F.; Yuan, L.; Yang, X.; Luo, L. New theoretical perspective for easy evaluation of the antioxidant properties of typical flavonoids. Microchem. J. 2024, 197, 109786. [Google Scholar] [CrossRef]
  61. Tao, Y.; Zhang, H.; Wang, Y. Revealing and predicting the relationship between the molecular structure and antioxidant activity of flavonoids. LWT Food Sci. Technol. 2023, 174, 114433. [Google Scholar] [CrossRef]
  62. Zhang, X.; Xu, J.K.; Wang, N.L.; Su, Y.B.; Yao, X.S. Antioxidant phenanthrenes and lignans from Denderobium nobile. J. Chin. Pharm. Sci. 2008, 17, 314–318. [Google Scholar]
  63. Sindt, L.; Gammacurta, M.; Waffo-Teguo, P.; Dubourdieu, D.; Marchal, A. Taste-guided isolation of bitter lignans from Quercus petraea and their identification in wine. J. Nat. Prod. 2016, 79, 2432–2438. [Google Scholar] [CrossRef]
  64. Li, S.; Jiang, S.X.; Jia, W.T.; Guo, T.M.; Wang, F.; Li, J.; Yao, Z.L. Natural antimicrobials from plants: Recent advances and future prospects. Food Chem. 2023, 432, 137231. [Google Scholar] [CrossRef]
  65. Farhadi, F.; Khameneh, B.; Iranshahi, M.; Iranshahy, M. Antibacterial activity of flavonoids and their structure–activity relationship: An update review. Phytother. Res. 2019, 33, 13–40. [Google Scholar] [CrossRef]
  66. Abbaszadeh, H.; Keikhaei, B.; Mottaghi, S. A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds. Phytother. Res. 2019, 33, 2002–2014. [Google Scholar] [CrossRef]
  67. Han, Q.H.; Wu, Z.L.; Huang, B.; Sun, L.Q.; Ding, C.B.; Yuan, S.; Zhang, Z.W.; Chen, Y.G.; Hu, C.; Zhou, L.J.; et al. Extraction, antioxidant and antibacterial activities of Broussonetia papyrifera fruits polysaccharides. Int. J. Biol. Macromol. 2016, 92, 116–124. [Google Scholar] [CrossRef] [PubMed]
  68. Zálešák, F.; Bon, D.J.Y.D.; Pospíšil, J. Lignans and neolignans: Plant secondary metabolites as a reservoir of biologically active substances. Pharmacol. Res. 2019, 146, 104284. [Google Scholar] [CrossRef] [PubMed]
Foods 13 02266 g001
Figure 1. Structures of compounds 1–17.
Figure 1. Structures of compounds 1–17.
Foods 13 02266 g001
Table 1. Weight in (Fr. A–I) of C. fasciculata.
Table 1. Weight in (Fr. A–I) of C. fasciculata.
Fractions (g)
A1 B*DEFGHIFr. II–III
6.162.614.527.165.639.532.815.7344.15/45.00
“1 B*” was obtained by combining the B and C fractions.
Table 2. Antioxidant activities of EtOAc extract and fractions of C. fascicularis.
Table 2. Antioxidant activities of EtOAc extract and fractions of C. fascicularis.
ComponentAntioxidant Activities
DPPH IC50/(µg/mL)ABTS IC50/(µg/mL)FRAP (500 µg/mL)
A50.33 ± 3.80 fg253.13 ± 8.40 d0.60 ± 0.04 e
1 B*97.43 ± 4.67 c41.04 ± 3.73 ef1.00 ± 0.01 c
D22.11 ± 1.30 h32.31 ± 3.30 ef1.15 ± 0.04 b
E89.45 ± 4.46 cd67.86 ± 2.12 ef0.67 ± 0.02 d
F34.60 ± 2.62 gh134.05 ± 10.49 e0.39 ± 0.01 f
G74.70 ± 3.43 de690.70 ± 26.41 b0.19 ± 0.01 g
H836.90 ± 32.06 a2237.67 ± 231.83 a0.11 ± 0.00 h
I350.73 ± 15.99 b406.60 ± 3.30 c0.17 ± 0.02 gh
EtOAc65.79 ± 4.41 ef330.61 ± 16.72 cd1.00 ± 0.07 c
2 Tetracycline28.91 ± 0.68 h13.51 ± 0.40 f2.17 ± 0.12 a
“1 B*” was obtained by combining the B and C fractions. “2”, positive control. Values accompanied by different letters are significantly different (p ≤ 0.05).
Table 3. Antibacterial activity of EtOAc extract and fractions in C. fascicularis.
Table 3. Antibacterial activity of EtOAc extract and fractions in C. fascicularis.
ComponentMIC mg/mL
E. coliS. aureusP. aeruginosa
A>20.00>20.00>20.00
B*>20.00>20.00>20.00
D>20.00>20.0010.00
E20.0020.0010.00
F20.00>20.0010.00
G>20.0020.00>20.00
H>20.0020.0010.00
I20.0020.0010.00
EtOAc>20.00>20.00>20.00
1 Penicillin0.06250.06250.25
1 Tetracycline0.015630.031250.125
“1”, positive control.
Table 4. Antioxidant activities of chemical constituents 1–17 in C. fascicularis.
Table 4. Antioxidant activities of chemical constituents 1–17 in C. fascicularis.
CompoundsABTS+ B Assay (%)
500 µg/mL100 µg/mL50 µg/mL10 µg/mL
198.88 ± 0.37 a-99.29 ± 0.83 a24.77 ± 2.14 d
26.84 ± 2.12 j---
399.74 ± 0.68 a-100.79 ± 1.66 a53.96 ± 1.89 a
489.18 ± 2.58 c58.48 ± 0.95 c--
554.80 ± 2.58 i-
657.43 ± 1.81 i---
755.88 ± 2.07 h---
886.48 ± 0.77 d66.00 ± 2.70 b--
999.47 ± 0.63 a-100.55 ± 0.06 a47.42 ± 1.89 b
1067.18 ± 1.62 f24.72 ± 2.23 e -
11101.03 ± 0.41 a-100.00 ± 0.00 a39.88 ± 3.15 c
1294.12 ± 0.99 b---
1383.34 ± 0.62 e53.38 ± 1.52 d--
1499.02 ± 0.59 a-101.11 ± 0.24 a25.71 ± 1.07 d
154.09 ± 1.65 k-
1658.89 ± 0.69 g- -
1799.94 ± 0.51 a-83.75 ± 0.65 b 40.61 ± 1.37 c
A ascorbic acid-99.85 ± 0.03 a61.78 ± 0.69 c25.00 ± 2.06 d
“A”, positive control; “B”, inhibition ratio; “-” indicates that the experiment was not performed. Values accompanied by different letters are significantly different (p ≤ 0.05).
Table 5. Antibacterial activity of chemical components 1–17 in C. fascicularis.
Table 5. Antibacterial activity of chemical components 1–17 in C. fascicularis.
CompoundMIC b µg/mL
E. coliS. aureusP. aeruginosa
1500.00500.00250.00
2500.00500.00-
3500.00500.00250.00
4500.00-125.00
5500.00500.00250.00
6500.00500.00250.00
7500.00500.00125.00
8500.00500.00250.00
9500.00500.00250.00
10500.00>500.00250.00
11>500.00500.00125.00
12500.00250.00125.00
13500.00500.00-
14500.00500.00250.00
15500.00500.00250.00
16500.00500.00250.00
17500.00500.00250.00
a Penicillin62.5062.50250.00
a Tetracycline15.6231.25125.00
“a”, positive control; “b”, minimum inhibitory concentration. “-” indicates that the experiment was not performed.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, R.; Tang, J.; Li, J.; Wu, B.; Tang, J.; Kan, H.; Zhao, P.; Zhang, Y.; Wang, W.; Liu, Y. Bioactivity-Guided Isolation of Secondary Metabolites with Antioxidant and Antimicrobial Activities from Camellia fascicularis. Foods 2024, 13, 2266. https://doi.org/10.3390/foods13142266

AMA Style

Li R, Tang J, Li J, Wu B, Tang J, Kan H, Zhao P, Zhang Y, Wang W, Liu Y. Bioactivity-Guided Isolation of Secondary Metabolites with Antioxidant and Antimicrobial Activities from Camellia fascicularis. Foods. 2024; 13(14):2266. https://doi.org/10.3390/foods13142266

Chicago/Turabian Style

Li, Ruonan, Jiandong Tang, Jingjing Li, Boxiao Wu, Junrong Tang, Huan Kan, Ping Zhao, Yingjun Zhang, Weihua Wang, and Yun Liu. 2024. "Bioactivity-Guided Isolation of Secondary Metabolites with Antioxidant and Antimicrobial Activities from Camellia fascicularis" Foods 13, no. 14: 2266. https://doi.org/10.3390/foods13142266

APA Style

Li, R., Tang, J., Li, J., Wu, B., Tang, J., Kan, H., Zhao, P., Zhang, Y., Wang, W., & Liu, Y. (2024). Bioactivity-Guided Isolation of Secondary Metabolites with Antioxidant and Antimicrobial Activities from Camellia fascicularis. Foods, 13(14), 2266. https://doi.org/10.3390/foods13142266

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop